Members of the Congressional Horse Caucus April 28 discussed the pros and cons of legislation that would grant the United States Anti-Doping Agency oversight of equine medication policy, testing, and enforcement.
Of the four parts of the National Uniform Medication Program, the multiple medication violation penalty system has been adopted by the lowest number of jurisdictions. But one official April 11 said he expects that to change.
An April 7 town hall meeting organized by the Association of Racing Commissioners International revealed consensus on the need for a central governing structure for horse racing, but little agreement on how to achieve it.
Six Standardbred trainers in New York were suspended after horses in their care registered extremely high levels of cobalt, and for three of them, the levels were so high the NYSGC issued 10-year bans per incident.
The New York State Gaming Commission has put together a proposed rule it hopes would add scrutiny to the practices of racetrack veterinarians.
Thoroughbred Horsemen's Association chairman Alan Foreman is confident a 2015 decision not to pursue a medication overage case against trainer Todd Pletcher won't negatively impact the National Uniform Medication Program.
Trainer Peter Moody, who said he will give up training and not appeal a six-month ban for a cobalt positive, went out a winner March 24 when the 6-year-old millionaire gelding Flamberge won the group I William Reid Stakes.
Regulations for cobalt have been adopted by the Ohio State Racing Commission, which will begin testing April 15 for the naturally occurring mineral that can adversely affect the equine health when given in large doses.
Racing industry won't resolve medication issues without unity read blog
The Jockey Club March 17 said its Graded Stakes Out-of-Competition Testing Grant Fund program again will be in effect in 2016.
A California Horse Racing Board Medication and Track Safety Committee meeting was often contentious at Santa Anita Park March 16, when topics regarding drug use and documentation were discussed.
The first of a two-part column on regulatory medication thresholds. read blog
Federal legislation that would grant the United States Anti-Doping Agency oversight of equine medication policy, testing, and enforcement has picked up additional sponsors in the U.S. House, officials said March 14.
The Kentucky Equine Drug Research Council has formed a committee to examine the 170 differences between its drug and medication classification schedule and RCI classifications.
The Los Angeles Superior Court determined March 10 that Los Alamitos Race Course house rules on clenbuterol and albuterol testing in Quarter Horse races violated state laws and that the CHRB should not have allowed the rules.
The New York Racing Association board of directors March 10 voted to support federal legislation that would grant USADA authority over equine medication and testing.
The American Quarter Horse Association said it remains committed to addressing misuse of medication in racing but a need for more resources has led it to suspend use of its multiple medication violation system pending review.
New York regulators Feb. 29 approved a ban on the last anabolic steroid that does not occur naturally in horses but has, until now, been permitted at specific threshold levels.
Legislation designed to modernize horse racing in Pennsylvania was signed into law Feb. 23 by Gov. Tom Wolf, who last fall threatened to shut down the industry because it couldn't pay for regulation.
The Racing Medication and Testing Consortium Feb. 19 issued an overview of its procedures in setting withdrawal times and drug-testing threshold levels after the National HBPA said it would pursue its own research.
Protocol in the testing of equine hair samples was the focus of a racing chemist's workshop organized by the Racing Medication and Testing Consortium and held at the University of California-Davis.
An organization formed to represent the interests of racetrack veterinarians has become proactive in the area of research into therapeutic medications and continues to make its case that vets should be part of drug reform.
The National HBPA Feb. 6 said it plans to help fund research to develop administration and testing guidelines that could be incorporated into the Controlled Therapeutic Medication Schedule.
Achieving true uniformity in equine medication and testing goes well beyond basic adoption of model rules, according to attorneys, horsemen, and veterinarians who picked apart the current system Feb. 5.
The ARCI plans an industry congress for the end of this year to develop consensus on equine medication and testing given its belief Congress won't be anywhere close to acting on legislation introduced last year.
An anti-doping task force in Ireland has issued recommendations designed to combat use of illegal drugs in racing and breeding and strengthen testing programs.
Medication, legislation, aftercare, and the importance of media awareness are among the topics to be discussed during the National Horsemen's Benevolent and Protective Association winter convention Feb. 3-7 in Florida.
New York regulators have given final approval to several equine drug rules, including a new system of minimum penalties for repeat drug violators.
The Thoroughbred industry has made meaningful progress in important areas such as medication, uniformity, and capitalizing on big events, but greater unity is needed going forward.
Perhaps research will end standoff
The Maryland Jockey Club has enacted a house rule for the Laurel Park meet that requires trainers of claimed horses to report joint injections administered in the previous 30 days.
A study designed to determine the levels of exercise-industry pulmonary hemorrhage in 2-year-olds racing in South Florida is complete, but the data won't be released until a scientific paper is published after peer review.
A Florida administrative law judge has recommended South Florida-based trainer Kirk Ziadie have his racing license suspended for six years and be fined $18,000 for repeated clenbuterol violations in 2012, 2013, and 2014.
Development of a central rule-making process for uniform medication policies and related implementation will be the 2016 focus for the Association of Racing Commissioners International.
The National Thoroughbred Racing Association announced that an updated set of racetrack safety and integrity standards has been approved by members of the NTRA Safety & Integrity Alliance Advisory Board and the NTRA board.
The first phase of an Ohio study into the effects the mineral cobalt has on horses showed that intravenous administration at high doses has detrimental effects on body systems.
The New York State Commission Nov. 23 proposed far-reaching equine drug rules as they slapped trainer Steve Asmussen with a $10,000 fine stemming from a probe into allegations of equine abuse brought against him by PETA.
State officials in Pennsylvania said they expect lawmakers the week of Nov. 16 to consider legislation that would, in part, stabilize the funding of horse racing regulation.
Standardbred racetrack owner Jeff Gural Nov. 12 said track owners should take the lead in improving integrity in the horseracing industry.
The New York State Gaming Commission has indefinitely suspended trainer Roy Sedlacek for two positives in October at Belmont Park for AH-7921, a synthetic opioid.
TOBA Nov. 2 said it will become a member of the Coalition for Horse Racing Integrity and support federal legislation that would allow USADA oversight over equine medication, drug testing, and enforcement.
Breeders' Cup has again expanded its welfare, safety, and integrity protocol for this year's World Championships, with a big assist from host track Keeneland.
The furosemide industry is a $3 million annual business for Thoroughbred racing in New York state, regulators said Oct. 26, with the average horse given $500 worth of doses in a typical year.
Host Lenny Shulman sits down with Breeders' Cup president and CEO Craig Fravel. Lenny also reflects on medication. Presented by Hill 'n' Dale Stallions watch video
The state of New York, citing costs savings, is considering a plan to halt a practice in which the state, at its expense, tests all claimed horses to check for the presence of drugs or other substances.
The California Horse Racing Board took steps toward new guidelines for medication violators, during its Oct. 22 meeting at Santa Anita Park that would prevent those violators from transferring horses to their employees.
- By Tom LaMarra
- Horse Health, Northeast Region, Midwest Region, Southeast Region, Southwest Region, West Region, Kentucky, Mid-Atlanic Region
The RMTC, which met Oct. 13, cited progress in state-by-state adoption of components of the National Uniform Medication Program and also added four drugs to the list of controlled substances.
Six members of Congress have announced their support for the Thoroughbred Horseracing Integrity Act of 2015, according to the Coalition for Horse Racing Integrity.
The California Horse Racing Board Oct. 9 said limits on the amount of the trace element cobalt that can be detected in racehorses officially took effect Oct. 5.
Kent Stirling, who has served as executive director of the Florida Horsemen's Benevolent and Protective Association since 1995, will transition out of the position this year.
Most Popular Stories
- Maiden Trojan Nation Seeks Derby Upset
- Ben's Cat Set for 10-Year-Old Debut
- Lani Works in Perplexing Fashion
- Nyquist Jogs in Advance of Final Derby Work
- First Winner for Caleb's Posse at Gulfstream
- Sherman Seeks California Chrome Stakes Upset
- 3 Kentucky Derby Longshots to Consider
- Horse Caucus Takes Testimony on Drug Bill
- Mad Flatter Euthanized After Accident
- Espinoza Back for More in Kentucky Derby